Enrollment completion in the OCU400 Phase 3 clinical trial combined with positive 3-year data from the Phase 1/2 study are important accomplishments in the Company’s plan to begin bringing this ...
Topline data of investigator-initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response ...
Dominique Thornton represents the future of mental health leadership. Her work turns advocacy into action and healing into ...
WINNIPEG, MB / ACCESS Newswire / March 4, 2026 / Consumer Choice Award is pleased to announce the 2026 award recipients in the Winnipeg region. These businesses have been meticulously selected through ...
Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets - ...
Johnson & Johnson (NYSE:JNJ) received FDA Fast Track designation for nipocalimab as a potential treatment for systemic lupus erythematosus, supported by positive Phase 2 data and the start of a Phase ...
After three months, OPGx-BEST1 was well tolerated with no reports of observed ocular inflammation or adverse events.
Duker indicated that EyePoint expects to report top line data for the Phase III LUGANO trial in mid-2026 with LUCIA data to follow closely, complete enrollment in the pivotal Phase III DME program in ...
For an actor such as Chris Hemsworth preparing for Thor or Hrithik Roshan getting ready for War, it is a “must”. There are ...
President Donald Trump on Monday pushed back against mounting criticism that he hasn’t done enough to explain why it was ...
The agreement will see Esperion, via a subsidiary, purchase all outstanding stock of Corstasis for an upfront cash payment of $75m.
Breast cancer mortality has decreased in high-income countries but increased in lower-income ones — a stark divide in outcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results